INFIQ — Infinity Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$17.75m
- $2.59m
- 30
- 56
- 13
- 24
Annual cashflow statement for Infinity Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.3 | -47.1 | -40.5 | -45.3 | -44.4 |
| Depreciation | |||||
| Non-Cash Items | 3.59 | 3.92 | 2.88 | 1.95 | 2.52 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.76 | 1.38 | 1.39 | 2.21 | -1.04 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -4.71 | -41.5 | -35.7 | -40.6 | -42.4 |
| Capital Expenditures | 0 | -2.33 | -0.043 | -0.011 | -0.017 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 13.1 | -9.91 | 14.7 | 5.5 | -0.038 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 13.1 | -12.2 | 14.6 | 5.49 | -0.055 |
| Financing Cash Flow Items | — | 27.6 | 19.6 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.62 | 27.7 | 27.4 | 87.1 | 0.073 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14 | -26 | 6.33 | 52 | -42.4 |